Cyprotex are hosting a series of webinars on the topic of drug transporters with speakers from Novartis, Genentech and Cyprotex. Join us each Wednesday in September.
Celonic is prepared to manufacture more than 100 million doses of CureVac’s mRNA-based COVID-19 vaccine candidate, CVnCoV, per year More than 50 million doses are expected to be produced before the e